Form 4: AngioDynamics Director Auen Receives Stock Grant as Annual Compensation

Director Eileen O'Shea Auen acquired 20,541 shares of AngioDynamics common stock as part of her annual compensation for serving on the board.

Summary

• Eileen O'Shea Auen, a director of AngioDynamics Inc. (ANGO), reported a transaction on July 17, 2024, where she acquired 20,541 shares of common stock.
• The acquisition represents restricted stock units granted as regular annual compensation for her service as a director.
• These restricted stock units vested immediately upon grant.
• Following the transaction, Auen beneficially owns 87,043 shares of AngioDynamics common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine director compensation event, which is generally neutral to slightly positive as it aligns director and shareholder interests.

Positives

• The grant of stock units to a director aligns their interests with those of the shareholders.
• Immediate vesting of the restricted stock units provides an immediate incentive for the director.

Industry Context

Director compensation in the form of stock grants is a common practice in publicly traded companies to align the interests of directors with those of shareholders. The size and vesting schedule of these grants can vary depending on the company's compensation policies and industry standards.

Comparison to Industry Standards

• Comparing the size of the stock grant to other directors in similar-sized medical device companies would provide context on whether the compensation is in line with industry norms.
• Companies like Medtronic, Boston Scientific, and Abbott Laboratories also use stock grants as part of their director compensation packages.
• Benchmarking against these companies would require analyzing their proxy statements and Form 4 filings.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• Employees may view the stock grant as a positive sign of the company's commitment to its leadership.

Key Dates